Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer

NCT04393285 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT04393285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 10, 2020
Completion date
December 31, 2026
Enrollment
53 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer